Exelixis Inc. Common Stock vs JFrog Ltd. Ordinary Shares — how do they compare? Exelixis Inc. Common Stock trades at $58.72 (market cap $14.62B), while JFrog Ltd. Ordinary Shares trades at $98.2 (market cap $11.99B). The key difference: Exelixis Inc. Common Stock is the larger of the two by market cap, and Exelixis Inc. Common Stock is more actively traded (2,684,957 versus 1,116,446). Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and JFrog Ltd. Ordinary Shares for 0 Days on average.
| EXEL | FROG | |
|---|---|---|
Market Cap | $14.62B | $11.99B |
Volume | 2,684,957 | 1,116,446 |
Sector | Health | Technology |
52-Week High | $59.13 | $104.03 |
52-Week Low | $34.54 | $34.75 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $13.95B | $11.18B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →JFrog provides software supply chain tools that help developers manage, secure, and distribute software packages. Its platform is used across development and deployment workflows.
Read more on FROG →